Obstetrics/Gynecology
RSSArticles
-
WHO Updates STI Treatment Guidance Due to Growing Antibiotic Resistance
The World Health Organization has issued new guidelines for the treatment of chlamydia, gonorrhea, and syphilis in response to the growing threat of antibiotic resistance. According to the international health organization, each year, 131 million people are infected with chlamydia, 78 million are infected with gonorrhea, and 5.6 million are infected with syphilis.
-
Deaths From Ovarian Cancer Fall Worldwide Due to Oral Contraceptive Use, Data Show
Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline through 2020 in the United States, European Union, and, to a lesser extent, in Japan, according to newly published research. The primary reason is the use of oral contraceptives and the long-term protection against ovarian cancer that they provide, say researchers.
-
LARC Options Expand With New Intrauterine Device
Family planning clinicians are adding another choice to the expanding list of long-acting reversible contraceptive options with the September 2016 FDA approval of the Kyleena 19.5 mg levonorgestrel IUD from Whippany, NJ-based Bayer HealthCare Pharmaceuticals. The new IUD is available as of October 2016 by prescription only.
-
Can the Human Papillomavirus Vaccine Cure Cervical Dysplasia?
In this randomized, controlled trial, the HPV 16/18 vaccine did not hasten resolution of existing oncogenic HPV infections nor prevent persistent HPV 16/18 associated infection and cervical dysplasia recurrence after loop electrosurgical excisional procedure treatment.
-
Should Perimenopausal Women Consider Estrogen Therapy?
A population-based study found that premenopausal women with low ovarian reserve, as determined by low levels of anti-Müllerian hormone, have unfavorable cardiovascular disease profiles.
-
Smoking Cessation and Preterm Birth
A study using Ohio state birth data showed that women who stopped smoking by the end of the first trimester had the same rates of preterm birth as nonsmokers. Women who stopped in the second trimester had preterm birth rates similar to those who smoked all the way through pregnancy.
-
New Prescription Drug Labeling for Pregnant and Nursing Women
The FDA has updated the requirements for the pregnancy and lactation sections of drug labeling to allow pregnant women and their healthcare providers to be better informed about the risks and benefits of medications while pregnant or nursing. This article discusses the new Pregnancy and Lactation Labeling Rule that went into effect in June 2015 and is being phased in over the next three to five years.
-
U.S. Preventive Services Task Force Recommends Against Genital Herpes Screening
The CDC estimates that about one in six U.S. residents ages 14-49 has genital herpes.1 In new draft guidance, the U.S. Preventive Services Task Force (USPSTF) recommends against using current blood tests to screen for genital herpes in people with no signs or symptoms of infection, including adolescents and adults, as well as pregnant women.2
-
The Trajectories of Vasomotor Symptoms Eyed Across the Menopausal Transition
Most women will get hot flashes or night sweats at some point during menopause. Research indicates 42% to 79% of women experience vasomotor symptoms (VMSs) during the menopausal transition.1-4 Just-published findings show that women fit into four distinct groups when it comes to having hot flashes and night sweats, which offers potential ramifications for therapy and prevention of future health conditions, according to research led by the Graduate School of Public Health at the University of Pittsburgh.5
-
Counsel on Convenience and Effectiveness Of Immediate Postpartum LARC
Unplanned pregnancies can happen in the postpartum period. Data indicate 40-57% of women report having unprotected intercourse before the routine six-week postpartum visit.1,2 The American College of Obstetricians and Gynecologists (ACOG) has just issued a new committee opinion on the use of long-acting reversible contraception (LARC) in the postpartum period to help stem such pregnancies.3